Northwest Biotherapeutics (NWBO) Accumulated Expenses (2010 - 2017)
Northwest Biotherapeutics' Accumulated Expenses was $933,000 in Q1 2017, down 21.5% from $1.19 million a year earlier but up 3.6% from the prior quarter.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Accumulated Expenses (2010 - 2017) Analysis & Trends
At the end of FY2016, Accumulated Expenses at Northwest Biotherapeutics came in at $901,000, down 31.2% from FY2015.
- Accumulated Expenses shows a five-year compound annual growth rate of -20.4% (FY2011 to FY2016).
- In earlier years, Accumulated Expenses was $1.31 million in FY2015 (+8.1%), $1.21 million in FY2014 (+43.8%), $842,000 in FY2013 (+43.0%) and $589,000 in FY2012 (-79.1%).
- Quarterly Accumulated Expenses has moved between $589,000 (Q4 2012) and $8.19 million (Q3 2012) over five years.
- Compared with a year earlier, Accumulated Expenses was higher in six of the last eight quarters, with growth averaging 16.6%.
- The best year-over-year quarter for Accumulated Expenses over five years was Q3 2012 (growth of 174.5%); the worst was Q3 2013 (a decline of 85.7%).
- Per Business Quant data, NWBO's Accumulated Expenses in the three quarters before Q1 2017 was $901,000 (Q4 2016), $1.3 million (Q3 2016) and $1.34 million (Q2 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Northwest Biotherapeutics | 250.40 Mn | 240.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 933,000.00 |
| Dec 31, 2016 | 901,000.00 |
| Sep 30, 2016 | 1.30 Mn |
| Jun 30, 2016 | 1.34 Mn |
| Mar 31, 2016 | 1.19 Mn |
| Dec 31, 2015 | 1.31 Mn |
| Sep 30, 2015 | 1.07 Mn |
| Jun 30, 2015 | 1.19 Mn |
| Mar 31, 2015 | 940,000.00 |
| Dec 31, 2014 | 1.21 Mn |
| Sep 30, 2014 | 790,000.00 |
| Jun 30, 2014 | 655,000.00 |
| Mar 31, 2014 | 756,000.00 |
| Dec 31, 2013 | 842,000.00 |
| Sep 30, 2013 | 1.17 Mn |
| Jun 30, 2013 | 1.09 Mn |
| Mar 31, 2013 | 1.08 Mn |
| Dec 31, 2012 | 589,000.00 |
| Sep 30, 2012 | 8.19 Mn |
| Jun 30, 2012 | 4.44 Mn |
API Access
Northwest Biotherapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();